113 related articles for article (PubMed ID: 15120707)
1. Diabetic rats treated by low molecular weight heparin OP 2123/parnaparin: morphological changes in the kidney and heart.
Artico M; De Santis S; Tranquilli Leali FM; Cavallotti D; Celestini A; Cavallotti C
J Diabetes Complications; 2004; 18(2):119-25. PubMed ID: 15120707
[TBL] [Abstract][Full Text] [Related]
2. [The protective effect of low molecular weight heparin on early nephropathy in diabetic rats].
Guo H; Gan L; Yu Z
Zhonghua Yi Xue Za Zhi; 2001 Nov; 81(21):1327-9. PubMed ID: 16200729
[TBL] [Abstract][Full Text] [Related]
3. Morphological changes in the sciatic nerve of diabetic rats treated with low molecular weight heparin OP 2123/parnaparin.
Artico M; Massa R; Cavallotti D; Franchitto S; Cavallotti C
Anat Histol Embryol; 2002 Aug; 31(4):193-7. PubMed ID: 12196260
[TBL] [Abstract][Full Text] [Related]
4. Influence of a low-molecular-weight heparin derivative on the nitric oxide levels and apoptotic DNA damage in adriamycin-induced cardiac and renal toxicity.
Deepa PR; Varalakshmi P
Toxicology; 2006 Jan; 217(2-3):176-83. PubMed ID: 16242830
[TBL] [Abstract][Full Text] [Related]
5. Biochemical evaluation of the inflammatory changes in cardiac, hepatic and renal tissues of adriamycin-administered rats and the modulatory role of exogenous heparin-derivative treatment.
Deepa PR; Varalakshmi P
Chem Biol Interact; 2005 Oct; 156(2-3):93-100. PubMed ID: 16154121
[TBL] [Abstract][Full Text] [Related]
6. Modulatory effect of bitter gourd (Momordica charantia LINN.) on alterations in kidney heparan sulfate in streptozotocin-induced diabetic rats.
Kumar GS; Shetty AK; Salimath PV
J Ethnopharmacol; 2008 Jan; 115(2):276-83. PubMed ID: 18024034
[TBL] [Abstract][Full Text] [Related]
7. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
Sun SZ; Wang Y; Li Q; Tian YJ; Liu MH; Yu YH
Chin Med J (Engl); 2006 May; 119(10):814-21. PubMed ID: 16732983
[TBL] [Abstract][Full Text] [Related]
8. Experimental diabetic nephropathy can be prevented by propolis: Effect on metabolic disturbances and renal oxidative parameters.
Abo-Salem OM; El-Edel RH; Harisa GE; El-Halawany N; Ghonaim MM
Pak J Pharm Sci; 2009 Apr; 22(2):205-10. PubMed ID: 19339234
[TBL] [Abstract][Full Text] [Related]
9. Tissue-specific regulation of insulin-like growth factors and insulin-like growth factor binding proteins in male diabetic rats in vivo and in vitro.
Han HJ; Kang CW; Park SH
Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1172-9. PubMed ID: 17184497
[TBL] [Abstract][Full Text] [Related]
10. The oxidant and antioxidant effects of 25-hydroxyvitamin D3 in liver, kidney and heart tissues of diabetic rats.
Noyan T; Balaharoğlu R; Kömüroğlu U
Clin Exp Med; 2005 May; 5(1):31-6. PubMed ID: 15928880
[TBL] [Abstract][Full Text] [Related]
11. Effects of STZ-induced diabetes and its treatment with vanadyl sulphate on cyclosporine A-induced nephrotoxicity in rats.
Saad SY; Najjar TA
Arch Toxicol; 2005 Sep; 79(9):493-9. PubMed ID: 15940472
[TBL] [Abstract][Full Text] [Related]
12. Rosiglitazone protects diabetic rats against kidney disease through the suppression of renal moncyte chemoattractant protein-1 expression.
Zheng M; Ye S; Zhai Z; Chen Y; Li X; Yang G; Fan A; Wang Y
J Diabetes Complications; 2009; 23(2):124-9. PubMed ID: 18413206
[TBL] [Abstract][Full Text] [Related]
13. Moderate exercise with a dietary vitamin C and e combination protects against streptozotocin-induced oxidative damage to the kidney and lens in pregnant rats.
Simşek M; Naziroğlu M; Erdinç A
Exp Clin Endocrinol Diabetes; 2005 Jan; 113(1):53-9. PubMed ID: 15662597
[TBL] [Abstract][Full Text] [Related]
14. Beneficial cardio-renovascular effects of a low-molecular-weight heparin-derivative on adriamycin-induced glycosaminoglycanuria and tissue lipid abnormalities.
Deepa PR; Varalakshmi P
Toxicology; 2005 Jul; 211(1-2):77-85. PubMed ID: 15863250
[TBL] [Abstract][Full Text] [Related]
15. Mammalian target of rapamycin pathway blockade slows progression of diabetic kidney disease in rats.
Lloberas N; Cruzado JM; Franquesa M; Herrero-Fresneda I; Torras J; Alperovich G; Rama I; Vidal A; Grinyó JM
J Am Soc Nephrol; 2006 May; 17(5):1395-404. PubMed ID: 16597691
[TBL] [Abstract][Full Text] [Related]
16. Hypolipidemic activity of 18beta-glycyrrhetinic acid on streptozotocin-induced diabetic rats.
Kalaiarasi P; Kaviarasan K; Pugalendi KV
Eur J Pharmacol; 2009 Jun; 612(1-3):93-7. PubMed ID: 19361497
[TBL] [Abstract][Full Text] [Related]
17. RAGE control of diabetic nephropathy in a mouse model: effects of RAGE gene disruption and administration of low-molecular weight heparin.
Myint KM; Yamamoto Y; Doi T; Kato I; Harashima A; Yonekura H; Watanabe T; Shinohara H; Takeuchi M; Tsuneyama K; Hashimoto N; Asano M; Takasawa S; Okamoto H; Yamamoto H
Diabetes; 2006 Sep; 55(9):2510-22. PubMed ID: 16936199
[TBL] [Abstract][Full Text] [Related]
18. Alterations in atrial natriuretic peptide and its receptor levels in long-term, streptozotocin-induced, diabetes in rats.
Obineche E; Chandranath I; Adeghate E; Benedict S; Fahim M; Adem A
Ann N Y Acad Sci; 2006 Nov; 1084():223-34. PubMed ID: 17151304
[TBL] [Abstract][Full Text] [Related]
19. Polyphenolic extract of Ichnocarpus frutescens attenuates diabetic complications in streptozotocin-treated diabetic rats.
Kumarappan CT; Mandal SC
Ren Fail; 2008; 30(3):307-22. PubMed ID: 18350451
[TBL] [Abstract][Full Text] [Related]
20. Cod liver oil supplementation improves cardiovascular and metabolic abnormalities in streptozotocin diabetic rats.
Ceylan-Isik A; Hünkar T; Aşan E; Kaymaz F; Ari N; Söylemezoğlu T; Renda N; Soncul H; Bali M; Karasu C;
J Pharm Pharmacol; 2007 Dec; 59(12):1629-41. PubMed ID: 18053324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
